Exposure to bacterial endotoxin, perhaps due to bowel congestion or ischaemia and altered gut permeability, may result in immune activation that is characteristic for patients with severe heart failure. It is known that blood procalcitonin rises in response to bacterial endotoxin exposure. We measured procalcitonin in a group of 29 patients with acute cardiogenic shock and no sign of infection (all without bacteraemia) and 26 with septic shock. Blood was analysed for procalcitonin, interleukin-6, tumour necrosis factor-alpha (TNF-alpha), c-reactive protein (CRP) and neopterin. Patients were managed conventionally in an intensive care unit with no further experimental procedures. Three cardiogenic (10%) and seven septic shock patients (27%) survived. Most patients with acute heart failure surviving 12 h or more (18 of 20) developed a pyrexia (738.0 degrees C) of unknown origin in the absence of positive cultures, with a rise in procalcitonin (1.4+/-0.8 to 48.0+/-16.2 ng/ml, P<0.001), CRP (76.5+/-16.4 to 154.7+/-22.9 mg/l, P<0.001) and neopterin (20.7+/-3.5 to 41.2+/-6.7 nmol/l, P<0.001). Patients with septic shock had higher initial levels of cytokines, and higher peak levels. Those with heart failure surviving (n=3) and those d...Continue Reading
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure
Evaluation of provocative tests in suspected medullary carcinoma of the thyroid:heterogeneity of calcitonin responses to calcium and pentagastrin
Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6.
Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis
Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart
Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy
Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials
C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery
Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology
Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention.
Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation
Fish oil-supplemented parenteral nutrition in patients following esophageal cancer surgery: effect on inflammation and immune function
Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation
Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis--a prospective, observational study
Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome.
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction
Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients
Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin
Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements
Effects of infectious disease on plasma lipids and their diagnostic significance in critical illness
Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome
Is the way to a man's heart through his stomach?: intestinal blood flow, gut permeability, and heart failure
The systemic inflammatory response syndrome predicts short-term outcome after transapical transcatheter aortic valve implantation
Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization
Is persistent hypotension after transient cardiogenic shock associated with an inflammatory response?
Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock
Prognostic and diagnostic value of elevated serum concentration of procalcitonin in patients with suspected heart failure. A review and meta-analysis
Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model
Inflammation and cardiovascular diseases: lessons that can be learned for the patient with cardiogenic shock in the intensive care unit
Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.
Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.